// App-Quantinova.ai

P4-01-21 : Analysis and single-cell retrieval of circulating tumor cells to monitor treatment response and assess genotype in triple-negative breast cancer

Researchers

Presenter

  • Ramirez A

Principal Investigators

  • Campton D

  • Mahen EBlau SBlau A

  • Kaldjian E

  • Stilwell J

Medical Centers

  • RareCyte Inc., Seattle, WA

  • Center for Cancer Innovation, University of Washington, Seattle, WANorthwest Medical Specialties, Puyallup, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Proto-oncogene tyrosine-protein kinase ROS

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved